Achillion Pharmaceuticals

INVESTORS

Press Releases

 
Press Releases
  Date Title View
Nov 29, 2004
Foster City, CA and New Haven, CT, November 29, 2004 — Gilead Sciences (Nasdaq: GILD) and Achillion Pharmaceuticals today announced that the companies have signed an exclusive agreement granting Gilead worldwide rights for the research, development and commercialization of certain Achillio...
PDF
Oct 13, 2004
NEW HAVEN, Conn. October 13, 2004 —Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging of infectious diseases, today announced the appointment of Gautam Shah, Ph.D. to the position of Vice President, Regulatory Affairs. Dr. Shah brings over sixteen year...
PDF
Sep 2, 2004
NEW HAVEN, Conn. September 2, 2004 —Achillion Pharmaceuticals, Inc., a leader in the discovery and development of small molecule drugs to combat the most challenging of infectious diseases, today announced the appointment of Michael D. Kishbauch as Chief Executive Officer. Mr. Kishbauch replaces interim CEO, Marios Fotiadis. Ac...
PDF
FirstPrevious
...
26